News & Insights

Who is the customer? Rabbit holes in Wonderland and the road to building compassionate connections

Could the magical allure of a white rabbit really ignite a renewed perspective on who our customer truly is? Seemingly this is something which worked for Alice as she traversed her own Wonderland. This article is the third in the 2024 series produced by the Pharmaceutical Marketing Society’s Digital Interest Group.

Chatting channels: IT as an enabler of customer engagement excellence

This Pharmaceutical Marketing Society article is based on a recent discussion between three members of the Digital Interest Group.

PM Society Digital Interest Group 2023 Year in Review

This article provided an overview of various thought-provoking articles published by the PM Society Digital Interest Group (DIG) throughout 2023.

A Seasonal Tale of Forgotten Marketing Toys

This article is the 13th in a series produced by the Digital Interest Group. It is an exciting time of year looking forward to next year’s projects with a new budget to spend, or perhaps quickly using up the remainder of this year’s budget before Scrooge in procurement takes it back.

The Pharma Field Team HCP Engagement Model of the Future

This article is the 12th in a series produced by the Pharmaceutical Marketing Society’s Digital Interest Group.

Bridging the Global-Local Divide: Achieving Content Excellence in Pharma

Delivering relevant, valuable and timely content at scale to healthcare professionals (HCPs) still proves a challenge for many global companies. But why?

Generative AI: hyper efficient or just plain hype?

The phrase “AI will not replace you, a person using it will” probably sums up how those working in #pharmamarketing and #medicalcommunications fields think about the acceleration we’ve seen in #AI since last November.

Modular Content: 5 Insights From Early Leaders in the UK

By 2025, 50% of content will be modular, according to The Veeva Executive Content Innovation Council.

How the future of doctor engagement is only a click away

Pharmaceutical companies have two main choices when looking to build and maintain relationships with doctors and other healthcare professionals (HCPs):